mitogen-activated protein kinase 8 ; Homo sapiens






6902 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
151 9670954 HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J Immunol 1998 Jul 15 3
152 9674701 Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 1998 Jul 16 15
153 9674706 Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene 1998 Jul 16 2
154 9682214 Bcl-2 regulates nonapoptotic signal transduction: inhibition of c-Jun N-terminal kinase (JNK) activation by IL-1 beta and hydrogen peroxide. Mol Genet Metab 1998 May 3
155 9686602 The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J Immunol 1998 Aug 1 7
156 9697658 Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis. J Am Soc Nephrol 1998 Aug 1
157 9699655 Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res 1998 Aug 1 1
158 9701025 Differential CD4-dependent inhibition of JNK but not Erk-2 activities in human naive and memory CD4+ T cell populations. Int Immunol 1998 Jul 2
159 9707514 Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+,K+-ATPase. Toxicol Appl Pharmacol 1998 Aug 9
160 9710210 Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes. Eur J Immunol 1998 Aug 2
161 9728050 Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am J Physiol 1998 Sep 8
162 9730903 D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells. Mol Pharmacol 1998 Sep 5
163 9731042 Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998 Sep 15 1
164 9740801 Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998 Sep 10 2
165 9743209 Antioestrogens enhance tumour necrosis factor receptor 2 (TNF-R2) expression and TNF-R2-mediated proliferation in activated T cells. Scand J Immunol 1998 Sep 9
166 9748273 Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 1998 Oct 2 1
167 9751169 Ca2+-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J Neurochem 1998 Oct 13
168 9756915 Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 1998 Oct 9 2
169 9759878 Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. J Immunol 1998 Oct 1 2
170 9762361 Tumor necrosis factor-alpha mediated activation of signal transduction cascades and transcription factors in 3T3-L1 adipocytes. Adv Enzyme Regul 1998 1
171 9774447 Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J Biol Chem 1998 Oct 23 8
172 9776729 p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res 1998 Oct 19 1
173 9786905 Analysis of human breast adenocarcinoma MCF7 resistance to tumor necrosis factor-induced cell death. Lack of correlation between JNK activation and ceramide pathway. J Biol Chem 1998 Oct 30 1
174 9790925 Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways. Biochem Biophys Res Commun 1998 Oct 9 8
175 9790955 Differential regulation of parallel mitogen-activated protein kinases in cardiac myocytes revealed by phosphatase inhibition. Biochem Biophys Res Commun 1998 Oct 9 1
176 9792916 Activation of c-Jun N-terminal kinase (JNK) by lysophosphatidic acid in Swiss 3T3 fibroblasts. J Biochem 1998 Nov 12
177 9808620 Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev 1998 Nov 1 1
178 9830045 Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 1998 Dec 4 2
179 9830064 TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem 1998 Dec 4 1
180 9837920 Analysis of the interaction between c-Jun and c-Jun N-terminal kinase in vivo. J Biol Chem 1998 Dec 11 1
181 9864179 Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood 1999 Jan 1 1
182 9867820 Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J Biol Chem 1999 Jan 1 2
183 9878062 c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 1999 Jan 4 3
184 9878764 Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons. Brain Res Dev Brain Res 1999 Feb 5 2
185 9880790 beta-hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide. J Biochem 1999 Jan 1
186 9882303 Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol 1999 Feb 1
187 9884018 Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: a brief overview. Cell Signal 1998 Nov 2
188 9886850 c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 1999 Jan 2
189 9890951 Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein beta gamma subunit in human embryonal kidney 293 cells. J Biol Chem 1999 Jan 22 1
190 9891069 Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol Cell Biol 1999 Feb 1
191 9891090 The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol Cell Biol 1999 Feb 2
192 9925763 Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells. Exp Cell Res 1999 Feb 1 1
193 9926932 ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 1999 Jan 7 2
194 9927052 Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. Cancer Res 1999 Jan 15 7
195 9927194 Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene 1999 Jan 14 14
196 9927384 Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. Am J Respir Crit Care Med 1999 Feb 1
197 9927621 No role for Ca++ or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Mol Pharmacol 1999 Feb 2
198 9931133 Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 1999 Jan 4
199 9935184 JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha. Int J Cancer 1999 Jan 29 1
200 10022881 The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol Cell Biol 1999 Mar 3